Orlov S. Nicole Schaeffer - Dec 28, 2023 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chief People Strategy Officer
Signature
/s/ S. Nicole Schaeffer, by Michael Smith as Attorney in Fact
Stock symbol
INSM
Transactions as of
Dec 28, 2023
Transactions value $
-$256,535
Form type
4
Date filed
1/2/2024, 04:04 PM
Previous filing
May 17, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $457K +22.3K +23.57% $20.49 117K Dec 28, 2023 Direct F1, F2
transaction INSM Common Stock Sale -$713K -22.3K -19.08% $32.00 94.5K Dec 28, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -22.3K -97.79% $0.00 503 Dec 28, 2023 Common Stock 22.3K $20.49 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 Includes 1,024 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F3 Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.